Shree Ganesh Remedies MD, chairman and AGM
NSE: SGRLBSE: 540737Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹658.00.
29 Oct: open ₹677.00, high ₹677.00, low ₹631.00
- Next results date: the board meets on 31 Oct 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹845 Cr1,715th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 54.73
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.18
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 10.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.19
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 10,493
Shree Ganesh Remedies' chairperson and managing director is CHANDULAL MANUBHAI KOTHIA, as filed for the quarter to Sep 2026. Its latest annual general meeting was on 12 Sep 2026.
Shree Ganesh Remedies board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- Chairperson and managing directorCHANDULAL MANUBHAI KOTHIA
- Company Secretary and Compliance OfficerAkanksha
6 directors4 independent2 executive
- CHANDULAL MANUBHAI KOTHIA · Chairperson and managing directorExecutive · joined Apr 1995 · reappointed Jul 2022 · 1 listed board · 2 committee seats
- PARTH CHANDULAL KOTHIAExecutive · joined Jan 2021 · reappointed Jan 2026 · 1 listed board · 1 committee seat
- MAULIKKUMAR JAYSUKHBHAI SUDANIIndependent · joined Jul 2023 · 38 months as independent · 1 listed board · 1 as independent · 2 committee seats, 2 as chair
- PARULBEN SAHANIIndependent · joined Jul 2023 · 38 months as independent · 1 listed board · 1 as independent · 1 committee seat
- SHRUTI RAJESH SOHANEIndependent · joined Aug 2025 · 13 months as independent · 2 listed boards · 2 as independent · 8 committee seats, 2 as chair
- HIRAL ANKITKUMAR SHAHIndependent · joined Jul 2026 · 2 months as independent · 1 listed board · 1 as independent
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
2 directors who left
- PRIYAM SURENDRA SHAH, left 7 Nov 2025: Others
- GUNJAN CHANDULAL KOTHIA, left 15 Sep 2025: Others
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 12 Aug 20266 of 6 present4 independent · 25 days in between
- 17 Jul 20265 of 5 present3 independent · 63 days in between
- 14 May 20265 of 5 present3 independent
Audit Committee
Chair MAULIKKUMAR JAYSUKHBHAI SUDANI
PARULBEN SAHANI, CHANDULAL MANUBHAI KOTHIA, SHRUTI RAJESH SOHANE
- 12 Aug 20264 of 4 present3 independent · 89 days in between
- 14 May 20264 of 4 present3 independent
Nomination and remuneration committee
Chair MAULIKKUMAR JAYSUKHBHAI SUDANI
PARULBEN SAHANI, SHRUTI RAJESH SOHANE
- 17 Jul 20263 of 3 present3 independent · 63 days in between
- 14 May 20263 of 3 present3 independent
Stakeholders Relationship Committee
Chair MAULIKKUMAR JAYSUKHBHAI SUDANI
CHANDULAL MANUBHAI KOTHIA, PARTH CHANDULAL KOTHIA, SHRUTI RAJESH SOHANE
- 12 Aug 20264 of 4 present2 independent · 89 days in between
- 14 May 20264 of 4 present2 independent
Corporate Social Responsibility Committee
Chair CHANDULAL MANUBHAI KOTHIA
MAULIKKUMAR JAYSUKHBHAI SUDANI, PARULBEN SAHANI, PARTH CHANDULAL KOTHIA
No meeting listed in the filing.
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Jun 2026.
- Chaudhary Shah & Associates LLPPeer-review certificate valid to Jun 2027
2 earlier auditors
- Chaudhary Shah and Associates LLPNamed in the filing for the quarter to Mar 2026
- Chaudhary Shah and Assoicates LLPNamed in the filing for the quarter to Mar 2025
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Shree Ganesh Remedies AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Shree Ganesh Remedies dividend history
Annual general meeting, 12 Sep 2026
8,255 shareholders on the register on 5 Sep 2026; present: 7 promoters and 43 others; votes counted by Vishal Thawani / VTSN & Associates LLP.The company's voting result
1. To receive, consider and adopt a. The Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2026, together with the Reports of the Board of Directors and the Auditors thereon. b. The Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, together with the Report of the Auditors thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 79.10% · promoters 100.00% · institutions 0.12% · other public 23.84%
- To consider a director in place of Mr. Chandulal Manubhai Kothia (DIN: 00652806), who retires by rotation and being eligible, offers himself for re-appointment.OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 79.10% · promoters 100.00% · institutions 0.12% · other public 23.84%
To consider and if thought fit, ratify the remuneration payable to M/s. M.I. Prajapati & Associates LLP, Cost Accountants, Cost Auditors of the Company, for the financial year ending March 31, 2027 and to pass, with or without modification(s), the resolution as an Ordinary Resolution.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 78.18% · promoters 100.00% · institutions 0.12% · other public 20.36%
To consider, and, if thought fit, to approve the appointment of Ms. Hiral Ankitkumar Shah (DIN: 07164025) as an Independent Director and in this regard, to pass with or without modification(s) the resolution as a Special Resolution.MoreLess
Special100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 78.18% · promoters 100.00% · institutions 0.12% · other public 20.36%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
How mutual funds voted
Fund houses must disclose how they vote at every meeting of a company they hold.
Mutual fund votes, meeting of 12 Sep 2026, 2 fund houses
1. To receive, consider and adopt a. The Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2026, together with the Reports of the Board of Directors and the Auditors thereon. b. The Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, together with the Report of the Auditors thereon.MoreLess
2 for0 against- To consider a director in place of Mr. Chandulal Manubhai Kothia (DIN: 00652806), who retires by rotation and being eligible, offers himself for re-appointment.2 for0 against
To consider and if thought fit, ratify the remuneration payable to M/s. M.I. Prajapati & Associates LLP, Cost Accountants, Cost Auditors of the Company, for the financial year ending March 31, 2027 and to pass, with or without modification(s), the resolution as an Ordinary Resolution.MoreLess
2 for0 againstTo consider, and, if thought fit, to approve the appointment of Ms. Hiral Ankitkumar Shah (DIN: 07164025) as an Independent Director and in this regard, to pass with or without modification(s) the resolution as a Special Resolution.MoreLess
2 for0 against
Mutual fund votes, meeting of 6 Apr 2026, 2 fund houses
To consider and approve related party transaction with Mr. Gunjan Chandulal Kothia, a related party under the provisions of Section 2(76) of the Act, being the son of Mr. Chandulal Kothia, Managing Director and brother of Mr. Parth Kothia, Whole-time Director and CFO of the Company, and holding an office or place of profit in the Company, for payment of remuneration up to Rs. 1,08,00,000/- per annum including variable pay together with other benefits, perquisites, allowances and facilities, as applicable, with authority to the Nomination and Remuneration Committee of the Board of Directors to decide the amount of remuneration payable to Mr. Gunjan Chandulal Kothia, from time to time, within the above limits approved by the members of the Company.MoreLess
Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
- Bandhan Mutual Fund, Motilal Oswal Mutual FundCompliant with law. No concern on the merits. Transparency concern: The Company has not disclosed the effective date of the proposed remuneration, and any retrospective approval would be non-compliant with law.
0 for2 againstTo consider and approve the re-appointment of Mr. Parth Chandulal Kothia (DIN: 08830608), as Whole-time Director in addition to act as Chief Financial Officer - Whole Time Key Managerial Personnel for a further period of 5 years effective from January 17, 2026 to January 16, 2031 and he shall be liable to retire by rotation, including remuneration.MoreLess
Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
- Bandhan Mutual Fund, Motilal Oswal Mutual FundCompliant with Law. No concerns are identified with regard to profile, time commitment and attendance of the Director. Governance concerns: The Board have been given an absolute discretion to vary/revised the terms remuneration without any further approval of members. The Company has not provided justification for significant increase in remuneration. Further, the Company had paid remuneration in excess of the approved limits.
0 for2 against
Each fund house counted once, from its own disclosure; the reasons are its own words.
Tax disputes
Reported in the filing for the quarter to Sep 2026.
- Tax disputeSuperintendent of Central GST and Central Excise Unit, VadodaraSince 18 Jul 2025
In accordance with the applicable requirements and pursuant to our appearance before the Department, the requisite submission was made on August 6, 2025, and was duly acknowledged. No further communication was received from the Department thereafter; accordingly, we understood that no further action was required from our end. Subsequently, following the transfer of the case from Vadodara to Ankleshwar, we were requested to furnish copies of the documents last submitted by us. We have duly furnished the same. As on date, no further documents or submissions have been sought from us, and we await further communication from the Department, if any.MoreLess
At the filing before: Summon have been issued and the investigation is at a preliminary stage alleging the violation(s) /contravention(s) committed involving the GST liability of approx. Rs. 88.61 Lacs.
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- Yes
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- Yes
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.